Navigation Links


Crossail at Biology News

Crossail at Biology Products
Crossail at Biology Technology
Crossail at Medicine News
Crossail at Medicine Products

Crossail

Description:The Crossail Coronary Dilatation Catheter provides a totally new design for advanced performance. Its proximal shaft transitions gradually to a more flexible distal shaft with a super-soft, flexible tapered tip. This results in a new level of cross, track and ease of use for both traditional rapid exchange balloon angioplasty and pre-dilatation procedures....
Company:Guidant Corporation
Crossail at Medicine Technology
Other TagsSantadaughterseducatedappearsscarscarleavesflipannuallyreservereserve
(Date:5/16/2008)...EWPORT BEACH, Calif., May 16 /PRNewswire-FirstCall...P ) announced today the promotion of David,M. Boit... Officer. "Dave,has made a tremendous contribution...y our strong investment growth and diversification... over $1 billion in accretive,investments for NHP,...
(Date:5/16/2008)...AN DIEGO, May 16 /PRNewswire-FirstCall/ -- CryoCor...cused on the treatment of cardiac,arrhythmias, ann...ers of,CryoCor common stock filed a complaint in t...ty of San Diego, naming as defendants each member ...Boston Scientific Corporation.,The complaint is st...
(Date:5/16/2008)...ment guidelines quickly disseminated to community ...16 (HealthDay News) -- Partnerships between major ...e a quick and effective way to spread cancer treat... Center in Philadelphia. , Most new cancer trea...ost cancer care is provided at community hospitals...
(Date:5/16/2008)...ismatch in some early stage cases makes therapy of...RIDAY, May 16 (HealthDay News) -- Colon cancer pat...need to receive chemotherapy. In fact, not only do..., it may actually harm them, a new study found. ,...ncer], then you should not be treated with chemoth...
Breaking Medicine News(10 mins):Health News:David M. Boitano Promoted to Senior Vice President 2Health News:CryoCor, Inc. Subject of Lawsuit Relating to Tender Offer and Merger 2Health News:CryoCor, Inc. Subject of Lawsuit Relating to Tender Offer and Merger 3Health News:CryoCor, Inc. Subject of Lawsuit Relating to Tender Offer and Merger 4Health News:Partnerships Effective Communicators of Cancer Advances 2Health News:Not All Colon Cancer Patients Need Chemotherapy: Study 2
(Date:5/15/2008)...eam of Penn State researchers has developed a simp...rganization and function of two of the most basic ...sm--the gelatinous fluid that surrounds the struct...creation of new drugs that take advantage of prope...ent of diseases. The team,s findings will be publ...
(Date:5/15/2008)... human race was divided into two separate groups w... says a Tel Aviv University mathematician. Climate...ions may have caused and maintained the separation...ematical Sciences at Tel Aviv University, worked w...l Center to analyze African DNA. Their goal was to...
(Date:5/15/2008)...Ill. (May 15, 2008) Argonne National Laboratory h... Savannah River National Laboratory (SRNL) to coll...ment research projects in support of critical U.S.... national priorities. , "The MOU allows Argonne ...gonne director Robert Rosner said. "Argonne has th...
(Date:5/15/2008)...nstitute researchers Karen Staehling-Hampton, Ph.D...vier Pourqui, Ph.D., Investigator, collaborated wi...enes known to cause spinal mutations in chick and ... human patients with congenital vertebral abnormal...he Web site of the American Journal of Human Genet...
Breaking Biology News(10 mins):Simple model cell is key to understanding cell complexity 2Long lost sisters 2Argonne-SRNL agreement supports critical DOE, national priorities 2Stowers Institute researchers identify gene linked to vertebral defects in patient populations 2Amicus Therapeutics to Present at the Merrill Lynch Global Pharmaceutical Biotech 26 Medtech 2007 Conference 521 1Amicus Therapeutics to Present at the Merrill Lynch Global Pharmaceutical Biotech 26 Medtech 2007 Conference 521 2Amicus Therapeutics to Present at the Merrill Lynch Global Pharmaceutical Biotech 26 Medtech 2007 Conference 521 3Senior Research Analyst Richard Evans Joins AVOS Life Sciences 518 1Senior Research Analyst Richard Evans Joins AVOS Life Sciences 518 2Phosphagenics to Commence Phase 2 TPM Insulin Clinical Trial 253 1Phosphagenics to Commence Phase 2 TPM Insulin Clinical Trial 253 2Phosphagenics to Commence Phase 2 TPM Insulin Clinical Trial 253 3Study by Pittsburgh researchers identifies possible vaccine target for chlamydia 358 1Study by Pittsburgh researchers identifies possible vaccine target for chlamydia 358 2
Other Contentsnucleusnucleusnucleusnucleusnucleusnucleusnucleusnucleusnucleuscellularcellularcellularcellularcellularcellularcellularcellularcellularcentriolecentriolecellulosecellulosecellulosecellulosecellulosecellulosecentromerecentromerechemiosmoticcentrosomecentrosomecentrosomesquaresquaresquaresquaresquaresquaresquare